Novo Nordisk and Ypsomed Selfcare Solutions

Novo Nordisk, a pharmaceutical gild founded in Denmark in 1923, has been a pioneer of innovative insulin delivery methods for the treatment of diabetes with brand names Levomir® (an dead reckoning pen that uses a pre-filled, replaceable insulin cartridge) and AERx® (an insulin inhalant). While Novo Nordisk continues to be the world leader in diabetes treatment, the caller has expanded into early(a) areas of research and development including human growth hormone and astringent products in their biopharmaceuticals. Biopharmaceuticals is the method of developing products by biological exercise preferably than chemical process often utilizing recombinant desoxyribonucleic acid, or DNA that is a combination of two or more organisms (Exploratorium, 2006). Ypsomed Selfcare Solutions, a company based in Burgdorf, Switzerland, was established in 2003 as a result of the split of the Burgdorf-based Disetronic Groups and is also involved in the medical checkup appliances and equi pment industry. Ypsomed is involved in the development and manufacture of custom-make injection pens and compatible pen needles for the administration of self-injection solutions by patients (Ypsomed Selfcare Solutions, 2003-2006). The companys products can lighten up be used for a variety of applications and therapies such as insulin therapy, growth hormone therapy, and osteoporosis and blood glucose monitoring. Ypsomed currently distributes its products primarily in Europe, but expect their market to grow worldwide due to the dramatic increase in diabetes cases.

PriceWaterhouseCoopers is the auditor of record s for these two companies (Ypsomed annual ! Report, 2005 and Novo Nordisk Annual Report, 2005). Novo Nordisk Financial Data-2005 Annual Report Novo Nordisk was the first Norse company to be quoted on the New York Stock Exchange, and is at once an outside(a) company with representation in 69 countries (Wikipedia, 2005). The 2005 annual conciliate states the company had a turnover of DKK 33.8 trillion, or approximately 4.5 jillion EUR (X-rates, 2006). Total sales for diabetes products... If you want to get a secure essay, order it on our website: BestEssayCheap.com

If you want to get a full essay, visit our page: cheap essay